Pilot Funding
ITHS Special WWAMI Awards
ITHS Small Pilot Project Grant
The new "Institute of Translational Health Sciences" (ITHS) was funded through the
NIH Clinical and Translational Science Award (CTSA). The ITHS brings together scientists at
the University of Washington (UW), Fred Hutchinson Cancer Research Center (FHCRC), Children's
Hospital and Regional Medical Center (CHRMC) and other partner institutions in the Puget Sound
region and in the WWAMI states to advance and transform clinical and translational research.
The ITHS is pleased to announce the availability of modest pilot grants in this special Call for
Applications for researchers in the WWAMI states. Grants are designed to assist investigators in
obtaining preliminary findings, testing "proof of concept," or conducting other research
activities designed to prepare and support competitive, full-scale grant applications. Applications
for planning grants that will facilitate collaboration among new investigator teams, or
established teams separated geographically will also be considered.
Purpose:
Applications will be considered that address any aspect of clinical or translational health science.
Examples of projects include, but are not limited to:
- Development of a serum-based test to diagnose colon cancer in patients with ulcerative colitis.
- Novel bioinformatics systems for analyzing proteomic data.
- Testing community-based translation and dissemination models for efficacious obesity-prevention programs.
- Planning activities to develop collaborative research among investigators studying AI/AN issues.
Typical awards will be in the $10,000 range (direct costs), with strong justification provided for
requests in excess of $10,000.
Eligibility and Review Criteria:
All researchers in the states of WA, WY, AK, MT, and ID are eligible to apply. Researchers in
the Puget Sound region (UW, FHCRC, CHRMC, Group Health Center for Health Studies, Benaroya
Research Institute) are not eligible to apply as Principal Investigators for this special round
of pilot funding, although they may participate as collaborators with researchers outside the
Puget Sound region.
- The proposed research MUST be readily identifiable as addressing issues in either translational or clinical research, or in career development in translational or clinical research (see below for definitions of clinical and translational research).
- It will be the responsibility of the PI to demonstrate the innovative aspects of the research and its potential to improve human health.
<
Application Process:
Complete the attached ITHS Small Grant Application Word document. Convert the file to pdf format.
Then e-mail the completed pdf file to Kathy Long at ithsapps@u.washington.edu
Applications must be received by May 1, 2008, 11:59PM.
Required format: Margins: .50; Font: Arial 11 pt regular. Do not exceed page limitations noted
for each section. Unsigned applications, or those not following the required format will be returned.
Download Special WWAMI Grant Application
For more information regarding the application process contact Kathy Long
at ithsapps@u.washington.edu or by phone at
(206) 598-4700.
Appendix: Definitions of Clinical and Translational Research Clinical Research:
NIH defines human clinical research as:
Patient-oriented research. Research conducted with human subjects (or on material of human origin
such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague)
directly interacts with human subjects. Excluded from this definition are in vitro studies that
utilize human tissues that cannot be linked to a living individual. Patient-oriented research
includes:
- mechanisms of human disease
- therapeutic interventions
- clinical trials
- development of new technologies
- epidemiologic and behavioral studies
- outcomes research and health services research
Source: NIH PHS 398 Instructions on Human Subjects Research
Translational Research:
Translational research includes:
- the process of making discoveries in the research laboratory or in preclinical studies that will have an impact on human health and may lead to the development of studies in humans,
- the process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans and
- research aimed at enhancing the adoption of best practices in the community.Cost-effectiveness of prevention and treatment strategies is also an important part of translational science.
Source: Based on Institutional Clinical and Translational Science Award (U54) RFA-RM-07-007 2007 CTSA RFA